Report overview
Artificial Intelligence in diabetes management is an automotion system which employs a computer system that gathers data, understands, reasons, and learns how the information effects outcomes over time.That the system ingests massive amounts of information?both structured and unstructured data?such as databases that have categorical variables, health records, and the scientific lexicon in research papers all of which is ingested and processed to make connections and then draw conclusions through a process of learning over time to increase in accuracy.
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence in Diabetes Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence in Diabetes Management. This report contains market size and forecasts of Artificial Intelligence in Diabetes Management in global, including the following market information:
Global Artificial Intelligence in Diabetes Management Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Artificial Intelligence in Diabetes Management market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Case-based Reasoning Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Artificial Intelligence in Diabetes Management include Apple, Diabnext, Glooko, Google, IBM, Tidepool and Vodafone, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Artificial Intelligence in Diabetes Management companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Artificial Intelligence in Diabetes Management Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Artificial Intelligence in Diabetes Management Market Segment Percentages, by Type, 2022 (%)
Case-based Reasoning
Intelligent Data Analysis
Global Artificial Intelligence in Diabetes Management Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Artificial Intelligence in Diabetes Management Market Segment Percentages, by Application, 2022 (%)
Glucose Monitoring Devices
Diagnostic Devices
Insulin Delivery Devices
Other Devices
Global Artificial Intelligence in Diabetes Management Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Artificial Intelligence in Diabetes Management Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Artificial Intelligence in Diabetes Management revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Artificial Intelligence in Diabetes Management revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Apple
Diabnext
Glooko
Google
IBM
Tidepool
Vodafone
Outline of Major Chapters:
Chapter 1: Introduces the definition of Artificial Intelligence in Diabetes Management, market overview.
Chapter 2: Global Artificial Intelligence in Diabetes Management market size in revenue.
Chapter 3: Detailed analysis of Artificial Intelligence in Diabetes Management company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Artificial Intelligence in Diabetes Management in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
